Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.
Sheetz M, Barrington P, Callies S, Berg PH, McColm J, Marbury T, Decker B, Dyas GL, Truhlar SME, Benschop R, Leung D, Berg J, Witcher DR.
Sheetz M, et al.
Br J Clin Pharmacol. 2019 May;85(5):935-948. doi: 10.1111/bcp.13877. Epub 2019 Mar 4.
Br J Clin Pharmacol. 2019.
PMID: 30677788
Free PMC article.
Clinical Trial.